Fabienne De Oliveira
Overview
Explore the profile of Fabienne De Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moisan A, Soares A, De Oliveira F, Alessandri-Gradt E, Lecoquierre F, Fourneaux S, et al.
Viruses
. 2023 May;
15(5).
PMID: 37243201
Since the end of 2020, multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) have emerged and spread worldwide. Tracking their evolution has been a challenge due...
2.
Moisan A, Mastrovito B, De Oliveira F, Martel M, Hedin H, Leoz M, et al.
Clin Infect Dis
. 2022 May;
75(10):1841-1844.
PMID: 35535770
In February 2022, samples collected in northwest France showed discordant molecular results. After virological and epidemiological investigations, 17 cases of Deltacron XD recombinant severe acute respiratory syndrome coronavirus 2 were...
3.
Mastrovito B, Naimi C, Kouam L, Naudot X, Fournier L, Spaccaferri G, et al.
Euro Surveill
. 2022 Feb;
27(6).
PMID: 35144722
Three confirmed infections with the SARS-CoV-2 B.1.640 variant under monitoring were reported in Normandy, north-western France in late November 2021. Investigations led to the identification of two events linked to...
4.
Leoz M, De Oliveira F, Plantier J
Virologie (Montrouge)
. 2020 Jan;
21(1):27-38.
PMID: 31967566
HIV-1 group O (HIV-1/O) are rare variants that are mainly found in Cameroon, where they represent several thousands of cases. The reasons for their limited diffusion remains poorly understood: their...
5.
Leoz M, De Oliveira F, Plantier J
Virologie (Montrouge)
. 2020 Jan;
21(1):1-11.
PMID: 31967564
HIV-1 group O (HIV-1/O) are rare variants that are mainly found in Cameroon, where they have caused several thousand cases. The reasons for their limited diffusion remain poorly understood: their...
6.
Wirden M, De Oliveira F, Bouvier-Alias M, Lambert-Niclot S, Chaix M, Raymond S, et al.
Euro Surveill
. 2019 Oct;
24(39).
PMID: 31576801
BackgroundEnding the HIV pandemic must involve new tools to rapidly identify and control local outbreaks and prevent the emergence of recombinant strains with epidemiological advantages.AimThis observational study aimed to investigate...
7.
De Oliveira F, Cappy P, Lemee V, Moisan A, Pronier C, Bocket L, et al.
AIDS
. 2018 Apr;
32(10):1289-1299.
PMID: 29683851
Background: The broad genetic divergence of HIV-1/O relative to HIV-1/M has important implications for diagnosis, monitoring and treatment. Despite this divergence, some HIV-1/M+O dual infections and HIV-1/MO recombinant forms have...
8.
Ngoupo P, Sadeuh-Mba S, De Oliveira F, Ngo-Malabo E, Ngono L, Plantier J, et al.
AIDS Res Hum Retroviruses
. 2018 Mar;
34(7):621-625.
PMID: 29575910
HIV-1 group N (HIV-1/N) remains rare and mainly restricted to Cameroon. In this study, we report a new HIV-1/N infected case identified during routine HIV screening activities in Yaounde. The...
9.
Alessandri-Gradt E, De Oliveira F, Leoz M, Lemee V, Robertson D, Feyertag F, et al.
AIDS
. 2018 Mar;
32(10):1317-1322.
PMID: 29547436
Objectives: HIV/1 group P (HIV-1/P) is the last HIV/1 group discovered and, to date, constitutes only two strains. To obtain new insight into this divergent group, we screened for new...
10.
Mourez T, Decroos A, Goria O, Montialoux H, De Oliveira F, Larrat S, et al.
J Med Virol
. 2018 Jan;
90(5):994-997.
PMID: 29350410
The use of new Direct Acting Antivirals, specific of HCV, has greatly improved the HCV treatment. Most of the DAA are specific of HCV genotypes. Genotyping methods may target different...